Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs - PubMed (original) (raw)
Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs
Cory Smith et al. Cell Stem Cell. 2014.
No abstract available
Similar articles
- Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N, Schwank G. Savić N, et al. Transl Res. 2016 Feb;168:15-21. doi: 10.1016/j.trsl.2015.09.008. Epub 2015 Sep 26. Transl Res. 2016. PMID: 26470680 Review. - Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
Liu KI, Ramli MNB, Sutrisnoh NB, Tan MH. Liu KI, et al. Methods Mol Biol. 2018;1772:267-288. doi: 10.1007/978-1-4939-7795-6_15. Methods Mol Biol. 2018. PMID: 29754234 - Plant genome engineering in full bloom.
Lozano-Juste J, Cutler SR. Lozano-Juste J, et al. Trends Plant Sci. 2014 May;19(5):284-7. doi: 10.1016/j.tplants.2014.02.014. Epub 2014 Mar 24. Trends Plant Sci. 2014. PMID: 24674878 - [CRISPR/Cas system for genome editing in pluripotent stem cells].
Vasil'eva EA, Melino D, Barlev NA. Vasil'eva EA, et al. Tsitologiia. 2015;57(1):19-30. Tsitologiia. 2015. PMID: 25872372 Review. Russian. - Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F, Lucier JF, Rodrigue S. Grenier F, et al. Methods Mol Biol. 2015;1334:233-44. doi: 10.1007/978-1-4939-2877-4_15. Methods Mol Biol. 2015. PMID: 26404154
Cited by
- Novel off-Targeting Events Identified after Genome Wide Analysis of CRISPR-Cas Edited Pigs.
Redel BK, Yoon J, Reese E, An H, Uh K, Chen PR, Prather RS, Lee K. Redel BK, et al. CRISPR J. 2024 Jun;7(3):141-149. doi: 10.1089/crispr.2024.0012. Epub 2024 May 21. CRISPR J. 2024. PMID: 38770737 - Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics.
Lopes R, Prasad MK. Lopes R, et al. Front Bioeng Biotechnol. 2024 Jan 18;11:1339189. doi: 10.3389/fbioe.2023.1339189. eCollection 2023. Front Bioeng Biotechnol. 2024. PMID: 38390600 Free PMC article. Review. - Combining Off-flow, a Nextflow-coded program, and whole genome sequencing reveals unintended genetic variation in CRISPR/Cas-edited iPSCs.
Shum C, Han SY, Thiruvahindrapuram B, Wang Z, de Rijke J, Zhang B, Sundberg M, Chen C, Buttermore ED, Makhortova N, Howe J, Sahin M, Scherer SW. Shum C, et al. Comput Struct Biotechnol J. 2023 Dec 29;23:638-647. doi: 10.1016/j.csbj.2023.12.036. eCollection 2024 Dec. Comput Struct Biotechnol J. 2023. PMID: 38283851 Free PMC article. - Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.
Chehelgerdi M, Behdarvand Dehkordi F, Chehelgerdi M, Kabiri H, Salehian-Dehkordi H, Abdolvand M, Salmanizadeh S, Rashidi M, Niazmand A, Ahmadi S, Feizbakhshan S, Kabiri S, Vatandoost N, Ranjbarnejad T. Chehelgerdi M, et al. Mol Cancer. 2023 Nov 28;22(1):189. doi: 10.1186/s12943-023-01873-0. Mol Cancer. 2023. PMID: 38017433 Free PMC article. Review. - Induction of local immunosuppression in allogeneic cell transplantation by cell-type-specific expression of PD-L1 and CTLA4Ig.
Zhu W, Li M, Zou J, Zhang D, Fang M, Sun Y, Li C, Tang M, Wang Y, Zhou Q, Zhao T, Li W, Hu Z, Hu B. Zhu W, et al. Stem Cell Reports. 2023 Dec 12;18(12):2344-2355. doi: 10.1016/j.stemcr.2023.10.016. Epub 2023 Nov 22. Stem Cell Reports. 2023. PMID: 37995700 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- P30 CA006973/CA/NCI NIH HHS/United States
- T32 HL007525/HL/NHLBI NIH HHS/United States
- 2R01-HL073781/HL/NHLBI NIH HHS/United States
- R01 HL073781/HL/NHLBI NIH HHS/United States
- U01-HL107446/HL/NHLBI NIH HHS/United States
- T32 GM007814/GM/NIGMS NIH HHS/United States
- U01 HL107446/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials